Results 21 to 30 of about 10,629 (135)

Dose–Response Association Between Systemic and Dermatologic Glucocorticoid Use and Type 2 Diabetes Mellitus: A Nationwide Case–Control Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 9, Page 8094-8102, September 2026.
ABSTRACT Aims To investigate the association and dose–response between systemic and topical glucocorticoids and odds of Type 2 diabetes mellitus. Materials and Methods We conducted a nationwide case–control study using Danish registry data from 2013 to 2021. People aged 40 years or older with incident type 2 diabetes mellitus (n = 149 113) were matched
David Vadsholt, Annika V. Kvist, Chano Sandiramoorthy, Joshua R. Lewis, Peter Vestergaard, Johan Røikjer, Nicklas H. Rasmussen   +6 more
wiley   +1 more source

Púrpura trombocitopênica idiopática e linfoma não-Hodgkin de células T na infância Idiopathic thrombocytopenic purpura and T-cell non-Hodgkin's lymphoma in childhood

Revista Brasileira de Hematologia e Hemoterapia, 2006
Os linfomas representam 10% de todos os tumores malignos da infância e, destes, os linfomas não-Hodgkin são os mais freqüentes. Crianças com doenças auto-imunes apresentam maior probabilidade de desenvolver doenças linfoproliferativas, podendo ocorrer ...
Alessandra C. Borges, Maria Pizza, Maria Luisa Borsato, Helena R. M. Silva, Helaine C. Castro, Silvia M. Luporini, Paula Bruniera   +6 more
doaj   +1 more source

Thrombotic Antiphospholipid Syndrome: A Long Term Follow‐up of Patients With Recurrent Pregnancy Loss and Antiphospholipid Antibodies From the APS 1994 Study

American Journal of Reproductive Immunology, Volume 96, Issue 1, July 2026.
ABSTRACT Problem There is a paucity of studies on the incidence and predictors of thrombotic antiphospholipid syndrome (APS) after pregnancy in patients with recurrent pregnancy loss (RPL) and antiphospholipid antibodies (aPL). This prospective study aimed to assess the long‐term prognosis, including the occurrence of thrombosis and associated risk ...
Minami Ashio, Tamao Kitaori, Yoshitaka Yano, Chihiro Banno, Shoko Ide, Hiroyuki Yoshihara, Shinobu Goto, Takahiro Otani, Mayumi Sugiura‐Ogasawara   +8 more
wiley   +1 more source

The Relationship Between Helicobacter Pylori Infection And Childhood Idiopathic Thrombocytopenic Purpura

مجلة كلية الطب, 2007
Background: Idiopathic thrombocytopenic purpura , a disorder characterized by autoantibody mediated platelets destruction causing decreased number of circulating platelets manifest as bleeding tendency.
Sawsan S. Abbas, Tariq M. Hadi
doaj  

Active pulmonary tuberculosis manifesting with idiopathic thrombocytopenic purpura: a rare presentation

Brazilian Journal of Infectious Diseases, 2010
A 17-year-old girl presented with a 3-day history of epistaxis, vaginal bleeding and petechiae over the lower extremities. The patient had been feeling unwell with productive cough, fever, chills, poor appetite and weight loss for 2 months.
Payam Tabarsi, Muayad Aghali Merza, Majid Marjani   +2 more
doaj   +1 more source

Platelet Transfusion Is Associated With Increased Thrombosis and In‐Hospital Mortality Among Patients Hospitalized With Platelet Consumptive Disorders

European Journal of Haematology, Volume 117, Issue 1, Page 245-257, July 2026.
ABSTRACT Background Platelet transfusion is commonly used to reduce bleeding risk in platelet consumptive disorders. However, platelets may also promote thromboinflammatory pathways, and contemporary data evaluating the association between platelet transfusion, thrombosis, and mortality in this population are limited.
Manas Pustake, Shubhangi Deoker, Veeravenkata Garikiparthy, Kunal Sharma, Lakshmi Kattamuri, Abhizith Deoker, Abhinav Deol   +6 more
wiley   +1 more source

Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura

Haematologica, 2008
Rituximab 375 mg/m2 weekly for four weeks has significant activity in patients with immune thrombocytopenia. We evaluated the activity of lower dose rituximab (100 mg iv weekly for 4 weeks) in 28 adults with idiopathic thrombocytopenic purpura.
Francesco Zaja, Marta Lisa Battista, Maria Teresa Pirrotta, Salvatore Palmieri, Michela Montagna, Nicola Vianelli, Luciana Marin, Margherita Cavallin, Monica Bocchia, Marzia Defina, Micaela Ippoliti, Felicetto Ferrara, Francesca Patriarca, Maria Antonietta Avanzini, Mario Regazzi, Michele Baccarani, Miriam Isola, Franca Soldano, Renato Fanin   +18 more
doaj   +1 more source

Thrombocytopenia and hyperthyroidism: A case report and literature review

Clinical Case Reports, 2023
Key Clinical Message Immune thrombocytopenic purpura (ITP) is very challenging to diagnose with concurrent comorbidities affecting platelet count including PAH and autoimmune thyroid disease.
Pitchaporn Yingchoncharoen, Mahmoud Abdelnabi, Jerapas Thongpiya, Alexandra Hoffman, Hira Tariq, Neha Mittal   +5 more
doaj   +1 more source

Síndrome de Evans - presentación atípica de un linfoma raro

Galicia Clínica, 2022
Evans Syndrome is a rare autoimmune condition characterized by two or more cytopenias, usually autoimmune haemolytic anaemia and immune thrombocytopenic purpura. It can be primary/idiopathic or secondary to other diseases.
Catarina Teles Neto, Marta Valentim, Filipa Pedro, Pedro Luís, Ana Gameiro, Luís Siopa   +5 more
doaj   +1 more source

Australian clinical practice guideline: diagnosis and treatment of idiopathic multicentric Castleman disease

Internal Medicine Journal, Volume 56, Issue 7, Page 1218-1239, July 2026.
Abstract Idiopathic multicentric Castleman disease (iMCD) is a rare condition. The pathogenesis is incompletely understood; however, interleukin‐6 (IL‐6) is a major mediator. The clinical presentation is heterogeneous, from mild constitutional symptoms to severe multi‐organ failure.
Dipti Talaulikar, Jun Yen Ng, Adam Bryant, Annmarie Bosco, Hugh C. Caterson, Pratyush Giri, Pravin Hissaria, Simon J. Harrison, Stephen Lade, Connull Leslie, Jacinta Perram, H. Miles Prince, Dejan Radeski, Maureen Rischmueller, Craig Wallington‐Gates, Nicholas Weber, Alberta Hoi   +16 more
wiley   +1 more source